Efficacy and safety of Chinese black tea (Pu-Ehr) extract in healthy and hypercholesterolemic subjects

Annals of Nutrition and Metabolism

Volumn 53, Issue 1, 2008, Pages 33-42

  Fujita, Hiroyuki ^a   Yamagami, Tomohide ^a  

^a Research and Development Department   (Japan)

Author keywords

Black tea extract; Cholesterol; Hypercholesterolemia; Metabolic syndrome; Pu Ehr

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BLACK TEA EXTRACT; C REACTIVE PROTEIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PROTEIN; SODIUM CHLORIDE; TRIACYLGLYCEROL; UREA;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ACUTE TOXICITY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CHOLESTEROL BILE LEVEL; CHRONIC TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DOSE CALCULATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE COUNT; FEMALE; FLATULENCE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RETCHING; SIDE EFFECT; SINGLE DRUG DOSE; TEA; THROMBOCYTE COUNT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

ACUTE TOXICITY TESTS; ADMINISTRATION, ORAL; ADULT; ANIMALS; BEVERAGES; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED ICR; MIDDLE AGED; PLANT EXTRACTS; TEA; TREATMENT OUTCOME; YOUNG ADULT;

ANIMALIA; CAMELLIA SINENSIS; MUS;

EID: 50649091140     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000153006     Document Type: Article

References (27)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971;74:1-12.
2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361, 662 men. Lancet 1986;ii:933-936.
3. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult treatment panel III) final report. Circulation 2002;106:3143-3421.
4. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
5. West of Scotland Coronary Prevention Study Group: Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study WOSCOPS. Circulation 1998;97:1440-1445.
6. Van Heek M, France CF, Compton DS, McLeod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR: In vivo metabolism-based discovery of potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997;283:157-163.
7. Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR: Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60633. Br J Pharm 2000;129:1748-1754.
8. Fujita H, Yokoyama K, Yoshikawa M: Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 2000;65:564-569.
9. Fujita H, Yamagami T, Ohshima K: Long-term ingestion of a fermented soybean-derived touchi-extract with α-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. J Nutr 2001;131:2105-2108.
10. Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL: Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res 1988;29:1573-1582.
11. Ostlund RE, Spilburg CA, Stenson WF: Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr 1999;70:826-831.
12. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6-14.
13. Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Fukuda N, Hasegawa Y: A novel use of chitosan as a hypocholesterolemic agent in rats. Am J Clin Nutr 1980;33:787-793.
14. Hori G, Wang MF, Chan YC, Komatsu T, Wong Y, Chen TH, Yamamoto K, Nagaoka S, Yamamoto S: Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers. Biosci Biotechnol Biochem 2001;65:72-78.
15. Yang TTC, Koo MWL: Hypocholesterolemic effect of Chinese tea. Pharma Res 1997;35:505-512.
16. Chan PT, Fong WP, Cheung YL, Huang Y, Ho WK, Chen Z-Y: Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 1999;129:1094-1101.
17. Kuo KL, Weng MS, Chiang CT, Tsai YJ, Lin-Shiau SY, Lin JK: Comparative studies of the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 2005;53:480-489.
18. Kimura Y, Watanabe K, Okuda H: Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats. J Ethnopharmacol 1996;54:47-54.
19. Tsuchida T, Itakura H, Nakamura H: Reduction of body fat in humans by long-term ingestion of catechins. Prog Med 2002;22:2189-2203.
20. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, Yayabe F, Sugano M: Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochem Biophys Acta 1992;1127:141-146.
21. Toris T, Satoh Y, Fujita H, Nagaoka T, Kawabata J: The structure and activity of Yunnan fermented tea on mixed bile salt micelles (in Japanese). Nippon Nougeikagakukaisi 2007;(suppl):261.
22. Fujita H, Yamagami T: Extract of black tea (Pu-Ehr) inhibits post-prandial rise in serum cholesterol in mice, and with long term use reduces serum cholesterol and low density lipoprotein levels and renal fat weight in rats. Phytother Res 2008; in press.
23. Saito Y (ed): Manual for the Treatment of Obesity, ed 2 (in Japanese). Tokyo, Ishiyaku Publishers, 2001.
24. Ballare M, Campanini M, Airoldi G, Zaccala G, Bertoncelli MC, Cornaglia G, Porzio M, Monteverde A: Hepatotoxicity of hydroxylmethyl-glutaryl-coenzyme A reductase inhibitors. Min Gastroenterol Dietol 1992;38:41-44.
25. Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, Laico M, Camerino DC: Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 1995;275:1490-1496.
26. Tal A, Rajeshawari M, Isley W: Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. South Med J 1997;90:546-547.
27. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I: Reduction of diet-induced obesity by a combination of tea-catechin intake and regular swimming. Int J Obes 2006;30:561-568.